• The clinical success rate for developing an analgesic is 2% - five times lower than other therapeutic areas.

 

  • Current treatment options are limited with only 1 in 8 people receiving satisfactory pain relief with standard of care. 

 

  • We have to change how we conduct R&D and link research to specific pain conditions to create precision-analgesics™.

Keys to Analgesic Innovation

01

understand the patient

Listen and learn from patients to create patient inspired R&D

02

Disease understanding

Increase knowledge of the 100+ conditions associated with chronic pain

03

link target to disease

Move away from relying on 'preclinical' data to define clinical development

04

Develop in the right patients

Break away from only developing in the  ~10 regulatory approved conditions

05

create the right patient outcomes

Develop patient outcome measures based on patients needs for each condition

06

increase female focused research

Take into account inherent gender bias and explore female pain conditions

Read & download this article on Analgesic Innovation. 

INFOGRAPHICS

Precision Analgeiscs Ai
Precision Analgeiscs 100 conditions

Further Reading 

(takes you to LinkedIn articles)

Woman in Pain
Image by Sharon McCutcheon
X-Ray Results

WOMEN IN PAIN

We need to change attitudes towards woman in pain & invest in female focused research.

THE BEST MEDICINE

The best medicine for pain: Personalised or Precision?

WHY ARE WE FAILING?

Why are we failing to develop new analgesics?

Creating new approaches to develop precision-analgesics™

©2020 by analgesicinnovation.